Alterations of the expression of transcription factors, epithelial–mesenchymal transition markers, oncogenes, tumor suppressor genes, and drug resistance-related genes upon SOX9 knockdown in comparison of primary and metastatic pancreatic cancer cells are discovered. This evidence concerns the gene SOX9 and familial pancreatic carcinoma.